Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Weight reduction via tirzepatide improves liver histology by reducing hepatic steatosis through sustained caloric deficit and improved insulin sensitivity the SURMOUNT trials showed significant reductions in ALT and AST alongside body weight loss
Novo Nordisk and Eli Lilly are currently the most dominant forces in this space and are expected to capture around 80% of the market share by 2030
"This involves a loss of volume in areas such as the cheeks, temples and jawline, which leads to an aged appearance, with looser skin and more pronounced features," explains Dr Beltrn
Yang Y, Li D, Wu W, Huang D, Zheng H, Aihaiti Y
US$ 28.28
US$ 21.12
US$ 27.80
US$ 22.97
